Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

Beijing Wehand-bio Pharmaceutical Co., Ltd

Clinical trials sponsored by Beijing Wehand-bio Pharmaceutical Co., Ltd, explained in plain language.

Completed 2
Sort by
  • New breast cancer drug shows promise in early trial

    Disease control Completed

    This early-phase study tested a new chemotherapy drug called WH002 against the standard drug paclitaxel in 40 women with HER2-negative breast cancer. Both drugs were given before surgery, followed by two other chemotherapy drugs. The main goal was to check safety and side effects…

    Phase: PHASE1 • Sponsor: Beijing Wehand-Bio Pharmaceutical Co., Ltd • Aim: Disease control

    Last updated May 17, 2026 02:08 UTC

  • Mulberry extract put to the test in early human safety trial

    Knowledge-focused Completed

    This early-stage study tested a tablet made from mulberry twig alkaloids (WH006) in 62 healthy and overweight/obese adults in China. The main goal was to check the drug's safety and how it moves through the body, not to treat obesity. Results will help decide if further studies a…

    Phase: PHASE1 • Sponsor: Beijing Wehand-Bio Pharmaceutical Co., Ltd • Aim: Knowledge-focused

    Last updated May 15, 2026 11:53 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space